Cillian King
Founder at Koala Life Sciences BV
Network origin in Cillian King first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Vrije Universiteit Amsterdam
34
| College/University | Other Consumer Services | 34 |
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies.
24
| Subsidiary | Investment Managers | 24 |
EQT Life Sciences Group BV
 EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands.
22
| Subsidiary | Investment Managers | 22 |
QurAlis Corp.
 QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA.
17
| Holding Company | Pharmaceuticals: Major | 17 |
Muna Therapeutics ApS
 Muna Therapeutics ApS Medical/Nursing ServicesHealth Services Muna Therapeutics ApS is a Danish private biopharmaceutical company that discovers and develops therapies to slow or stop neurodegenerative diseases such as Alzheimer's, frontotemporal dementia, and Parkinson's. Muna Therapeutics is based in Copenhagen, DK and was founded in 2020 by Simon Glerup and Bart de Strooper. The company focuses on identifying new medicines to preserve cognition and other brain functions and enhance resilience to these diseases. Rita Balice-Gordon has been the CEO of the company since 2020.
10
| Holding Company | Medical/Nursing Services | 10 |
Sairopa B V
 Sairopa B V MiscellaneousMiscellaneous Sairopa B V is a Dutch company that develops medicines and operates as an investment holding company.
3
| Private Company | Miscellaneous | 3 |
Allero Therapeutics BV
 Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Allero Therapeutics BV is a biopharmaceutical company, which engages in the development of immunotherapies. It focuses on the research and development pipeline with a focus on a celiac disease product and a food allergy product. The company was founded by Poul Sorensen, Emil Pot, Federico Grego, and Kees Leenhouts and is headquartered in Rotterdam, the Netherlands.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Cillian King via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| NOVO NORDISK A/S | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal | |
| SANOFI | Biotechnology | Director/Board Member Corporate Officer/Principal | |
BMEYE BV
 BMEYE BV Electronic Equipment/InstrumentsElectronic Technology BMEYE BV operates as a non-invasive cardiovascular monitoring company. The firm manufactures and distributes non-invasive technology, hemodynamic monitoring equipment and related medical devices. It offers finger arterial pressure and cardiac output technologies. The company was founded in April 2005 and is headquartered in Amsterdam, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
Van Lanschot Kempen Investment Management NV
 Van Lanschot Kempen Investment Management NV Investment ManagersFinance Van Lanschot Kempen Investment Management NV (Van Lanschot Kempen) is a specialist wealth manager headquartered in Amsterdam, Netherlands. The firm was founded in 1991 and was formerly known as Kempen Capital Management NV. They are a wholly-owned subsidiary of Van Lanschot Kempen NV (AMS: VLK). Van Lanschot Kempen administers Dutch pension funds and provides integral asset management for Dutch institutional clients. | Investment Managers | Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Fixed Income Portfolio Manager-Equities | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Public Communications Contact Chief Investment Officer | |
| Imperial College London | College/University | Corporate Officer/Principal Doctorate Degree | |
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
| NEXSTIM PLC | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
| University of Amsterdam | College/University | Undergraduate Degree Doctorate Degree Director/Board Member Graduate Degree Undergraduate Degree Director/Board Member Graduate Degree Graduate Degree Graduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| Erasmus University Rotterdam | College/University | Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree | |
| University of Leiden | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
| University of Utrecht | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Undergraduate Degree | |
| Katholieke Universiteit Leuven | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| Radboud University Nijmegen | College/University | Doctorate Degree General Counsel | |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
The Royal Netherlands Academy of Arts & Sciences
 The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Netherlands Academy of Arts & Sciences provides research services in the field of science and art. The private company is based in Amsterdam, Netherlands and has subsidiaries in Netherlands. The CEO of the Dutch company is Wilma de Koning. | Miscellaneous Commercial Services | President Director/Board Member | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
| CELYAD ONCOLOGY SA | Biotechnology | Director/Board Member Corporate Officer/Principal | |
McKinsey & Co., Inc. (Belgium)
 McKinsey & Co., Inc. (Belgium) Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consultancy services. It serves businesses, governments, non governmental organizations, and non-profit organizations. The company was founded by James O. McKinsey in 1926 and is headquartered in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
INKEF Capital BV
 INKEF Capital BV Investment ManagersFinance INKEF Capital BV is an Independent Venture Capital firm founded in 2010 by Frank R Landsberger. INKEF Capital BV is headquartered in Amsterdam. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Neuravi Ltd.
 Neuravi Ltd. Medical SpecialtiesHealth Technology Neuravi Ltd. designs and develops medical devices for the treatment of acute stroke. Through its investment in the Neuravi Thromboembolic Initiative the company supports collaboration between engineers, clinicians and researchers to deepen the understanding of clot and occlusion dynamics to improve patient outcomes in stroke. Neuravi The company was founded by Mahmood K. Razav, Eamon Brady, John O'Shaughnessy and David Vale in 2009 and is headquartered in Galway, Ireland. | Medical Specialties | Director/Board Member Director/Board Member | |
LSP Advisory BV
 LSP Advisory BV Investment ManagersFinance Part of LSP Advisory Group BV, EQT Life Sciences is a healthcare investment firm based in Amsterdam, Netherlands. EQT Life Sciences has been connecting investors to inventors in the healthcare sector for over 30 years. The Dutch company has invested in close to two hundred private companies, raising billions of additional capital directed at supporting their R & D. EQT Life Sciences believes in fostering life and constant innovation in healthcare to achieve that goal. The company was founded in 1998, and Mark A. Wegter has been the CEO since then. Recently, EQT Life Sciences was acquired by EQT AB, one of the largest private equity firms in Europe, and among the top-ten private equity firms globally. | Investment Managers | Director/Board Member Chief Executive Officer | |
Asceneuron SA
 Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
ViCentra BV
 ViCentra BV Electronic Equipment/InstrumentsElectronic Technology ViCentra BV engages in the development of medical devices. It focuses in creating devices for diabetes patients. The company was founded by Tim Oakes and Joseph John Cefai in 2013 and is headquartered in Utrecht, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
| Rotterdam School of Management | College/University | Graduate Degree Graduate Degree | |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
| PHARVARIS N.V. | Pharmaceuticals: Major | Director/Board Member Founder | |
Onward Medical SA
 Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
| Stichting VUmc | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
NMD Pharma A/S
 NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Biotechnology | Director/Board Member Director/Board Member | |
Merck Ventures BV
 Merck Ventures BV Investment ManagersFinance Merck Ventures BV (Merck Ventures) is a venture capital arm of Merck KGaA founded in 2009. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Private Equity Analyst Private Equity Analyst | |
Varmx BV
 Varmx BV BiotechnologyHealth Technology VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018. | Biotechnology | Director/Board Member Director/Board Member | |
Bolster Investment Partners BV
 Bolster Investment Partners BV Investment ManagersFinance Bolster Investment Partners BV (Bolster Investment Partners) is an independent private equity firm. The firm was founded by Mark van Rijn, Joost Bakhuizen, Michiel van Wissen and Paul Vogelzang in 1982. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Private Equity Investor | |
NodThera Ltd.
 NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Biotechnology | Director/Board Member Chairman | |
Enclear Therapies, Inc.
 Enclear Therapies, Inc. Pharmaceuticals: MajorHealth Technology Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA. | Pharmaceuticals: Major | Founder Founder | |
Xilis, Inc.
 Xilis, Inc. Medical SpecialtiesHealth Technology Xilis, Inc. engages in the development of droplet-based microfluidics technology devices for precision cancer diagnostics and drug development. It offers Xilis platform. The company was founded by Xiling Shen and David Shu and is headquartered in Durham, NC. | Medical Specialties | Founder Director/Board Member | |
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Founder Director/Board Member Director/Board Member | |
| ONWARD MEDICAL N.V. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Health Economics Privak II NV
 Health Economics Privak II NV Finance/Rental/LeasingFinance Health Economics Privak II NV is a Belgian company that provides credit intermediation services. The private company is based in De Pinte, Belgium. The company was founded in 2017. | Finance/Rental/Leasing | Director/Board Member Director/Board Member |
Statistics
International
| Netherlands | 24 |
| Belgium | 8 |
| United States | 7 |
| Denmark | 6 |
| France | 3 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 11 |
| Finance | 10 |
| Commercial Services | 4 |
| Electronic Technology | 3 |
Operational
| Director/Board Member | 326 |
| Corporate Officer/Principal | 100 |
| Private Equity Investor | 72 |
| Graduate Degree | 54 |
| Chairman | 50 |
Most connected contacts
| Insiders | |
|---|---|
| Anne Michelle Whitaker | 35 |
| Martijn Kleijwegt | 33 |
| René Kuijten | 30 |
| Roel Bulthuis | 29 |
| Rudy Dekeyser | 29 |
| Luc Dochez | 26 |
| Dharminder Singh Chahal | 25 |
| Jacqueline Rijsdijk | 24 |
| Lise Kingo | 23 |
| Alexandra Elisabeth Schaapveld | 22 |
| John Paul de Koning | 21 |
| Henrijette Richter | 21 |
| Isaac E. Ciechanover | 16 |
| Anne Portwich | 16 |
| Vincent Brichard | 15 |
- Stock Market
- Insiders
- Cillian King
- Company connections